| Pharmaceutical active ingredients: |
| Tazarotene |
| Available forms, composition and doses of Avage: |
| Cream; Topical; Tazarotene 0.1% |
| Avage medical category: |
| Human:Acne treatment preparationsPsoriasis, seborrhea and ichthyosis preparationsSkin and mucous membrane agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D05AX05 - Tazarotene |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-AventisAllerganIDS Group |
| Related documents and information about Avage: |
| Avage prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Audax | Choline Salicylate | Sanofi-Aventis |
| Auditol | Phenazone; Procaine | Sanofi-Aventis |
| Auralgicin | Benzocaine; Chlorobutanol; Ephedrine Hydrochloride; Phenazone; Potassium Hydroxyquinoline Sulfate | Sanofi-Aventis; Roche |
| Auraltone | Benzocaine; Phenazone | Sanofi-Aventis |
| Auxergyl D3 | Vitamin A; Vitamin D3 (Cholecalciferol) | Sanofi-Aventis |
| Avalide | Hydrochlorothiazide; Irbesartan | Sanofi-Aventis; Bristol-Myers Squibb |
| Avamigran Suppositories | Caffeine; Camylofin Hydrochloride; Ergotamine Tartrate; Mecloxamine Citrate; Propyphenazone | Sanofi-Aventis |
| Avaxim | Hepatitis A Vaccine inactivated | Sanofi-Aventis; Merck; ProMedico; Zuellig Pharma |
| Avaxim Paediatric | Hepatitis A Vaccine inactivated | Sanofi-Aventis |
| Avaxim Pediatric | Hepatitis A Vaccine inactivated | Sanofi-Aventis; Zuellig Pharma |